Market Overview

Irregular Heartbeat Drug Development Pipeline Analysis Report 2018 - ResearchAndMarkets.com

Share:

The "2018
Irregular Heartbeat Drug Development Pipeline Analysis Report-
Companies, Drugs, Clinical Trials, Latest Developments in Irregular
Heartbeat Market"
report has been added to ResearchAndMarkets.com's
offering.

Irregular Heartbeat refers to abnormal rate of heart beats and effects
around 6 million people in the US alone. More than 20% of these patients
are hospitalized and 8-9% witness death. The pace of heart beat is
irregular, or either more than the normal range (tachycardia) or slower
than normal (bradycardia). Primary factors contributing to the Irregular
Heartbeat condition include diabetes, smoking, stress while symptoms
include palpitations, short of breath etc.

To assist researchers, investors and business development managers, the
publisher has come up with a comprehensive report on Irregular Heartbeat
pipeline. The report provides insights into different therapeutic
candidates in preclinical, research, discovery, NDA/IND, pre
registration, phase 1, phase 2, and phase 3 trials). Drugs under
development directly and through combination with other drugs are also
included.

Current status, developmental phase, participating companies and
entities, recent developments, orphan drug/ fast track/ other
designations, drug class are provided for each Irregular Heartbeat
pipeline product. Mechanism of Action and the target area of the
pipeline product are also provided. Further, clinical and preclinical
trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key
trends in Irregular Heartbeat pipeline studies. The products under
development are categorized according to their development phase,
mechanism and company to provide detailed insights into the type of
drugs being developed and the stages of development.

Companies Mentioned

  • AETAS Pharma Co.,Ltd
  • Armgo Pharma, Inc.
  • Beijing CoSci Med-Tech Co.,Ltd
  • Gilead Sciences, Inc.
  • HUYA Bioscience International, LLC
  • InCarda Therapeutics, Inc.
  • LATITUDE Pharmaceuticals Inc.
  • Milestone Pharmaceuticals Inc.
  • Numerate, Inc.
  • OMEICOS Therapeutics GmbH
  • Ono Pharmaceutical Co., Ltd.
  • Sanofi SA
  • Servier Laboratories Limited
  • Sign Path Pharma Inc

Key Topics Covered:

1 Table of Contents

2 Irregular Heartbeat Pipeline Analysis

3 Irregular Heartbeat- Company Wise Pipeline Analysis

4 Irregular Heartbeat R&D Pipeline Snapshots

5 Recent Developments in Irregular Heartbeat Pipeline

6 Appendix

For more information about this report visit https://www.researchandmarkets.com/research/n7d7rr/irregular?w=4

View Comments and Join the Discussion!